TMTC4 and benign prostatic hyperplasia: To the best of our knowledge, this is the first study to report the expression pattern of TMTC4 in PCa cells and tissue specimens and highlight its ability to differentiate between the tumor and BPH tissues with high sensitivity and specificity, a finding that can be carried over to clinical practice after further validation.